Moneta Group Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Moneta Group Investment Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$236K	Buy
2022 Q1	–	Sell
2021 Q4	$261K	Sell
2021 Q3	$403K	Buy
2021 Q2	$575K	Buy
2021 Q1	$432K	Buy